As a part of its Corporate Social Responsibility, for the benefit of thalassemic children, Transasia Bio-Medicals Ltd., once again joined hands with PATUT, to organize ‘Nayaab Lamhe’, a musical concert by the hugely acclaimed Padmashree Pankaj Udhas, on 2nd March 2019 at Mumbai.
For over ten years now, Transasia and Parent Association Thalassemic Unit Trust (PATUT), have been actively associated in the commitment to the cause of thalassemic children.
With a purpose higher than just business, Transasia, India’s leading In-vitro Diagnostic Company operates on a simple conviction, to be available to Doctors and in-turn their patients at all times, with quality and affordable diagnostic solutions that offer early and accurate results for timely treatment of diseases. Transasia’s instruments, of international standards, have helped accurately diagnose thalassemia in innumerable patients across the country, giving them a ray of hope. Over the last two years, Transasia has organized awareness camps in more than 12 colleges across Mumbai and conducted screening tests on more than 2500 students. Infact, PATUT and Transasia have together organized numerous dedicated initiatives such as blood donation drives, equipping diagnostic centres with the required instruments and contributing to fund-raising activities for the benefit of thalassemic children.
PATUT is a non-profitable organization set up by parents who leave no stone unturned to ensure that their thalassemic children get a second chance at life. Through its association with various hospitals, PATUT arranges and mobilizes funds for Bone Marrow Transplant (BMT), a last resort procedure for most thalassemic children. So far, PATUT has arranged funds and sponsored 150 BMTs in the last five years.
As the President of PATUT, Ghazal maestro Pankaj Udhas has been showcasing his talent for the cause of thalassemia for over three decades. Infact, his relentless contribution to both the fields has been duly honored by the Government of India with the prestigious Padmashree award!
At the ‘Nayaab Lamhe’ concert, Pankaj Udhas set the mood with his soulful, romantic and timeless ghazals.
Speaking at the occasion, Suresh Vazirani, Chairman & Managing Director, Transasia said, “I am immensely proud of Transasia’s continuing ten year old association with PATUT, Smt. Jasmine Majethia and Padmashree Pankaj Udhas in aid of a very noble cause of thalassemic children. From helping four children in 1982 to establishing centres for spreading awareness, detection, counseling and prevention of thalassemia, the impact of the good work done by PATUT has spread far and beyond. At Transasia, we believe in operating with a higher purpose, with an unwavering focus on our customers and the patients they serve. Thalassemia is a cause we very closely associate with. We are glad that with our hematology range of analyzers, we are able to contribute to the early and accurate diagnosis of thalassemia and its associated adversities, giving the patients a chance for timely treatment.”
“We are proud that as we mark our 40th anniversary, we are able to contribute to this cause in ways more than one. Nothing motivates me more than the fact that my entire Transasia family resonates this intent”, he further added.
More than 400 pathologists from across the city, attended the event on behalf of Transasia. Dr. V. H. Juvekar, General Manager, Haffkine Biopharmaceutical Corporation Ltd. remarked, “Thalassemia is a growing concern for the country. Today, 35-45 million Indians, are carriers of beta-thalassemia, which translates to 3-4% of India’s population. It is heart rending to see so many young children, loosing their lives to the condition, for want of a Bone Marrow Transplant. Transasia and PATUT are doing a splendid job, to reach out to these children. I am thankful to Transasia for giving me an opportunity to be a part of this wonderful evening of soulful ghazals by Pankaj Udhas and to see his dedication towards this noble cause.”
About Transasia Bio-Medicals Ltd.:
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics.
Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 300+ service and application support specialists, 400+ sales and marketing team, 24 zonal offices and 350+ distributors.
It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world.
All along its journey spanning more than three decades, Transasia has been recognized for its commitment to healthcare. The Govt. of India recently bestowed Transasia with ‘The India Medical Devices Export Company of the Year’ award amongst many others. Besides this, Transasia was conferred the Best Medical Equipment Company of the Year-2017’ by Medgate Today and the ‘Economic Times- Best Healthcare Brand 2016’ amongst many others.
Headquartered in Mumbai, Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba –Transasia Group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions.
Erba’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables.Today, the Erba -Transasia Group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com